On ECHEMI
Home > Drugs > Viral hepatitis
Viral hepatitis
Viral hepatitis (including A, B and non-A, non-B) is a legal infectious disease with the characteristics of strong infectiousness, complex transmission routes, wide prevalence and high incidence rate. Some patients with B and non-A, non-B hepatitis may develop chronic diseases, which is very harmful to people's health. According to etiological diagnosis, there are at least 5 types of hepatitis viruses, namely A, B, C, D and E viruses, which cause A, B, C, D and E viral hepatitis, namely hepatitis A (hepatitis A), hepatitis B (hepatitis B), hepatitis C (hepatitis C), hepatitis D (hepatitis D) and hepatitis E (hepatitis E). Another type is called G viral hepatitis, which is less common. Among them, A and E mainly manifest as acute hepatitis, B, C and D mainly manifest as chronic hepatitis and may develop into hepatitis cirrhosis and hepatocellular carcinoma. The pathogenicity of hepatitis G virus and TTV virus is still controversial. In addition, many other known viruses, such as cytomegalovirus, Epstein-Barr virus, yellow fever virus, rubella virus, herpes simplex virus, coxsackie virus, and ECHO virus, can also cause liver inflammation. Clinically, the main manifestations are fatigue, loss of appetite, nausea, vomiting, hepatomegaly, and liver damage. Some patients may have jaundice and fever. Some patients experience urticaria, joint pain, or upper respiratory tract symptoms.
  • Site of disease:

    liver
  • Infectious :

    Contagious
  • Frequent population:

    No special disease group
  • Related symptoms:

    Tension of liver capsule massive liver cell necrosis proteinuria big three positive nausea
  • Concurrent disease:

Related Drugs
Xuesetong Injection
Manufacturer:

Langzhi Group Wanrong Pharmaceutical Co., Ltd.

Diammonium Glycyrrhizinate Capsules
Indication: This product is suitable for the treatment of acute and chronic viral hepatitis accompanied by elevated alanine aminotransferase.
Manufacturer:

CHIA TAI Tianqing Pharmaceutical Group Co., Ltd.

Diammonium Glycyrrhizinate Capsules
Indication: This product is suitable for the treatment of acute and chronic viral hepatitis accompanied by elevated alanine aminotransferase.
Manufacturer:

Jiangsu Runbang Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.